©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 111171
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.111171
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.111171
Figure 2 Kaplan-Meier survival curves to evaluate the survival outcomes of patients in the validation set.
A: Disease-free survival outcomes of patients in the validation set; B: Overall survival outcomes of patients in the validation set. aP < 0.05.
- Citation: Li SJ, Lu YX, Zheng FY, Bian YC, Miao LY, Huang CR. Tumour chemotherapy sensitivity test may predict clinical outcomes in colorectal cancer patients receiving oxaliplatin and fluoropyrimidine-based regimens. World J Gastrointest Oncol 2025; 17(11): 111171
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/111171.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.111171